Skip to content

West Pharmaceutical Services Inc

WST· NYSECore metricsCIK 105770

Surgical & medical instruments & apparatus142 peers

Last sale
Nov 12, 2026 · -0.40%
Market cap
$28.66B
69.66M shares
Filings
1,031
$874.50M
Q3 2026+6.3% FY25 yoy
$214.00M
Q3 2026+0.2% FY25 yoy
$267.40M
Q3 2026+2.6% FY25 yoy
$278.40M
Q3 2026derived+69.6% FY25 yoy
$3.02
Q3 2026+1.5% FY25 yoy
$464.10M
Q3 2026+63.3% FY25 yoy
$28.66B
44.9×
8.4×
9.7×
1.58%
0.22%

Twelve months to Sep 30, 2026 · derived

Price

$411.37+48.40%+$134.16past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$3.07BFY 2025
$3.07B0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$3,074,100,000reported
FY 20242024-12-31$2,893,200,000reported
FY 20232023-12-31$2,949,800,000reported
FY 20222022-12-31$2,886,900,000reported
FY 20212021-12-31$2,831,600,000reported
FY 20202020-12-31$2,146,900,000reported
FY 20192019-12-31$1,839,900,000reported
FY 20182018-12-31$1,717,400,000reported
FY 20172017-12-31$1,599,100,000reported
FY 20162016-12-31$1,509,100,000reported
FY 20152015-12-31$1,399,800,000reported
FY 20142014-12-31$1,421,400,000reported

Capital returns

Dividends and buybacks · FY2016 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025$61.20M$134.00M$195.20M$0.8672.02M sh−0.4%41.6%
FY2024$59.10M$560.90M$620.00M$0.8272.30M sh−1.4%224.3%
FY2023$57.00M$438.30M$495.30M$0.7873.30M sh−1.1%119.5%
FY2022$54.10M$202.80M$256.90M$0.7474.14M sh−0.2%58.5%
FY2021$51.10M$137.10M$188.20M$0.7074.28M sh+0.2%56.9%

Segments

Revenue by Segments, FY2021 to FY2025FY2021Proprietary Products · FY2021 · $2.32BContract-Manufactured Products · FY2021 · $514.70MFY2022Proprietary Products · FY2022 · $2.41BContract-Manufactured Products · FY2022 · $480.40MFY2023Proprietary Products · FY2023 · $2.40BContract-Manufactured Products · FY2023 · $552.50MFY2024Proprietary Products · FY2024 · $2.33BContract-Manufactured Products · FY2024 · $558.70MFY2025Proprietary Products · FY2025 · $2.49BContract-Manufactured Products · FY2025 · $582.00M
LineFY2025ShareChange
Proprietary Products$2.49B81%+6.8%
Contract-Manufactured Products$582.00M19%+4.2%
Total$3.07B

From the 10-K filed Feb 17, 2026WST

Surgical & medical instruments & apparatus

West Pharmaceutical Services Inc is the 11th largest of the 143 covered companies the SEC files under this code, by revenue. SIC 3841

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

West Pharmaceutical Services Inc · CIK 105770 · Engraved from SEC EDGAR